Correlated Stock Forecasts

Assets that tend to move strongly with SGEN



DUOL Forecast + Options Trading Strategies   Duolingo (0.74)


PARA Forecast + Options Trading Strategies   Paramount Global (0.48)


ZM Forecast + Options Trading Strategies   Zoom Video Communications (0.46)


GME Forecast + Options Trading Strategies   Gamestop (0.41)


ARKG Forecast + Options Trading Strategies   ARK Investment Management LLC - ARK Genomic Revolution (0.39)



Uncorrelated Stock Forecasts

Assets with little price relationship to SGEN



UUP Forecast + Options Trading Strategies   Invesco DB US Dollar Index Bullish (-0.04)


JNUG Forecast + Options Trading Strategies   Direxion Daily Junior Gold Miners Index Bu (-0.06)


KSS Forecast + Options Trading Strategies   Kohl's (0.08)


AMAT Forecast + Options Trading Strategies   Applied Materials (0.09)


V Forecast + Options Trading Strategies   Visa (0.13)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against SGEN



AIG Forecast + Options Trading Strategies   American International (-0.41)


LLY Forecast + Options Trading Strategies   Lilly(Eli) (-0.41)


DRI Forecast + Options Trading Strategies   Darden Restaurants (-0.45)


LMT Forecast + Options Trading Strategies   Lockheed Martin (-0.46)


WMT Forecast + Options Trading Strategies   Walmart (-0.49)


SGEN News over Time





Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.

Most Recent SGEN News
















Bullish Case: Seagen's cancer therapies have caught the attention of the world's largest drugmakers, and Pfizer has agreed to buy the biotech company for $43 billion [The Wall Street Journal].


Bearish Case: Analysts are conflicted on Seagen's future, and the stock has already risen significantly on the news of a potential acquisition [Business Insider, Business Insider].


Takeaway: Seagen's pioneering cancer treatments have made it an attractive acquisition target for big drugmakers, and a potential $43 billion deal with Pfizer could be a major boon for shareholders [The Wall Street Journal, geekwire.com].


March 14, 2023